An International Study on Pediatric Patients With Rare Tumors.

Sponsor
Azienda Ospedaliera di Padova
Study ID
NCT07072143
Status
Recruiting
Apply to this trial

Conditions

  • Adrenocortical Tumor
  • Appendiceal Cancers
  • Esthesioneuroblastoma, Olfactory
  • Gastrointestinal Stromal Tumor (GIST)
  • Melanoma and Other Malignant Neoplasms of Skin
  • Mesothelioma
  • NUT Carcinoma
  • Nasopharyngeal Carcinoma (NPC)
  • Pancreatic Tumors
  • Paraganglioma/ Phaeochromocytoma
  • Pleuropulmonary Blastoma
  • Salivary Gland Tumors
  • Thymic Tumors
  • Thyroid Carcinoma

Eligibility Criteria

Sex
ALL
Age
0 Years - 18 Years
Healthy Volunteers
Not accepted

Study Details

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Key Dates

First listed
Jul 18, 2025
Start date
Jan 25, 2025
Status verified
Jul 2025
Primary completion
Jan 6, 2049
Completion
Jun 6, 2049

Study Design

Enrollment
6,250 participants (estimated)

Primary Outcome Measure

Epidemiology [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Related Studies